ctrl K

Greenwich LifeSciences In... (GLSI)

NASDAQ: GLSI · Real-Time Price · USD

9.95

-0.03 (-0.30%)

At close: May 02, 2025, 3:59 PM

9.99

0.45%

After-hours: May 02, 2025, 04:02 PM EDT

Greenwich LifeSciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K
Gross Profit	n/a	-3.61K	-3.61K	-3.61K	-3.61K	-3.61K	-3.61K	-3.61K
Operating Income	-16.01M	-9.33M	-8.04M	-4.6M	-1.86M	-3.43M	-1.69M	-1.57M
Interest Income	223.01K	436.06K	215.02K	27.37K	832.00	n/a	n/a	n/a
Pretax Income	-15.79M	-8.89M	-7.83M	-4.57M	-1.86M	-3.43M	-1.69M	-1.57M
Net Income	-15.79M	-8.89M	-7.61M	-4.54M	-1.86M	-3.43M	-1.69M	-1.57M
Selling & General & Admin	3.06M	1.63M	1.56M	1.04M	806.19K	818.89K	419.64K	346.81K
Research & Development	12.95M	7.7M	6.48M	3.56M	1.06M	2.61M	1.27M	1.22M
Other Expenses	n/a	-0.00	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	16.01M	9.33M	8.04M	4.6M	1.86M	3.43M	1.69M	1.57M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	9.33M	8.04M	4.6M	1.86M	3.43M	1.69M	1.57M
Income Tax Expense	n/a	n/a	-215.02K	-27.37K	-832	3.00	-157.53K	3.00
Shares Outstanding (Basic)	13.01M	12.85M	12.91M	12.94M	12.7M	11.74M	11.97M	11.74M
Shares Outstanding (Diluted)	13.01M	12.85M	12.91M	12.94M	12.7M	11.74M	11.97M	11.74M
EPS (Basic)	-1.21	-0.69	-0.59	-0.35	-0.15	-0.29	-0.14	-0.13
EPS (Diluted)	-1.21	-0.69	-0.59	-0.35	-0.15	-0.29	-0.14	-0.13
EBITDA	-15.79M	-9.32M	-8.04M	-4.59M	-1.86M	-3.42M	-1.69M	-1.57M
EBIT	n/a	-9.33M	-8.04M	-4.6M	-1.86M	-3.43M	-1.69M	-1.57M
Depreciation & Amortization	n/a	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K